Brain Tumors Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Tumors, including details on symptoms, benign and malignant tumors, gliomas, screening, treatment. | ||||||||
|
Frequency of retinal cavernomas in 60 patients with familial cerebral cavernomas: a clinical and genetic study.Labauge P, Krivosic V, Denier C, Tournier-Lasserve E, Gaudric A Department of Neurology, Centre Hospitalo-Universitaire de Montpellier-Nîmes, Montpellier, France. labauge@hotmail.com OBJECTIVES: To define the frequency of retinal lesions in a large panel of patients with familial cerebral cavernomas and to screen the cerebral cavernous malformation genes in patients with cerebral and retinal lesions. METHODS: Fundus examination was proposed to each of the index patients of 70 families with cerebral cavernous malformation who have been included in a prospective clinical and neuroradiological follow-up. All of the coding exons of the KRIT1, MGC4607, and PDCD10 genes were screened as previously described. RESULTS: Of the 70 index patients, 60 were consecutively examined. The 10 remaining patients refused the fundus examination. Three of the 60 examined patients had a retinal cavernoma diagnosis. Three mutations were found: a point mutation within exon 5 of the KRIT1 gene, a large deletion that encompassed exons 1 and 2 of the MGC4607 gene, and a large genomic de novo deletion encompassing the whole PDCD10 gene. CONCLUSIONS: Retinal cavernoma frequency can be estimated to be about 5% of the patients with familial cerebral cavernomas. Retinal cavernomas are not restricted to KRIT1 mutation carriers but can be observed in patients carrying a mutation in any of the 3 cerebral cavernous malformation genes. CLINICAL RELEVANCE: Five percent of patients with familial cerebral cavernomas have retinal cavernomas. These lesions are clinically asymptomatic. They can be associated with any of the 3 cerebral cavernous malformation genes. Published 13 June 2006 in Arch Ophthalmol, 124(6): 885-6.
© 2004-2008 Brain Tumors Research Today. All Rights Reserved. |
| ||||||
